Effect of Systemic Corticosteroid Therapy on Risk for Intra-Abdominal or Pelvic Abscess in Non-operated Crohn’s Disease

2005 ◽  
Vol 3 (12) ◽  
pp. 1215-1220 ◽  
Author(s):  
Anurag Agrawal ◽  
Shireen Durrani ◽  
Keith Leiper ◽  
Anthony Ellis ◽  
Anthony I. Morris ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Corticosteroid Therapy ◽  
Systemic Corticosteroid ◽  
Pelvic Abscess ◽  
Systemic Corticosteroid Therapy

Topical corticosteroids in ulcerative colitis

1975 ◽  
Vol 13 (2) ◽  
pp. 5-7
Keyword(s):  
Ulcerative Colitis ◽  
Corticosteroid Therapy ◽  
Systemic Corticosteroid ◽  
Extensive Disease ◽  
Double Blind ◽  
Topical Corticosteroids ◽  
Systemic Corticosteroid Therapy ◽  
Blind Trials

Since the usefulness of topical corticosteroids in the treatment of ulcerative colitis was first reported1 double-blind trials have confirmed their effectiveness, and they are now widely used.2 For disease localised to the rectum suppositories, and for more extensive disease, retention enemas containing various corticosteroids are available (see table). In severe cases these preparations also valuably supplement systemic corticosteroid therapy, with or without sulphasalazine (Salazopyrin).

scholarly journals Development of uveitis during systemic corticosteroid therapy in TINU syndrome

2011 ◽  
Vol 26 (7) ◽  
pp. 1177-1178 ◽  
Author(s):  
Sebastiano A. G. Lava ◽  
Oliver Bucher ◽  
Barbara S. Bucher ◽  
Giacomo D. Simonetti ◽  
Sibylle Tschumi
Keyword(s):  
Corticosteroid Therapy ◽  
Systemic Corticosteroid ◽  
Tinu Syndrome ◽  
Systemic Corticosteroid Therapy

Central Serous Chorioretinopathy Complicating Systemic Corticosteroid Therapy

1997 ◽  
Vol 7 (3) ◽  
pp. 297-300 ◽  
Author(s):  
A.M. Abu El-Asrar
Keyword(s):  
Idiopathic Thrombocytopenic Purpura ◽  
Corticosteroid Therapy ◽  
Central Serous Chorioretinopathy ◽  
Systemic Corticosteroid ◽  
Spontaneous Recovery ◽  
Systemic Treatment ◽  
Steroid Treatment ◽  
Thrombocytopenic Purpura ◽  
Present Evidence ◽  
Systemic Corticosteroid Therapy

Purpose. To present evidence that systemic corticosteroid therapy may cause central serous chorioretinopathy. Methods. A 20-year-old male with idiopathic thrombocytopenic purpura was examined during systemic treatment with corticosteroids (100 mg daily). Results. The patient had central serous chorioretinopathy. Spontaneous recovery accompanied discontinuation of the steroid treatment. Conclusions. This case provides further evidence that Cortisol may play a role in the development of central serous chorioretinopathy.

Sign in / Sign up

Export Citation Format

Share Document